PL348640A1 - Use of parvovirus capsid particles in the inhibition of cell proliferation and migration - Google Patents

Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Info

Publication number: PL348640A1
Authority: PL; Poland
Prior art keywords: migration; inhibition; cell proliferation; parvovirus capsid; capsid particles
Prior art date: 1998-11-24

Application number

PL99348640A

Inventor

Kristina Broliden

Magnus Westgren

Original Assignee

Kristina Broliden

Magnus Westgren

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-24

Filing date

1999-11-23

Publication date

2002-06-03

1999-11-23 Application filed by Kristina Broliden, Magnus Westgren filed Critical Kristina Broliden

2002-06-03 Publication of PL348640A1 publication Critical patent/PL348640A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Cardiology (AREA)
Surgery (AREA)
Virology (AREA)
Hematology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL99348640A 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration PL348640A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9804022A SE520177C2 (en)	1998-11-24	1998-11-24	Use of empty, non-infectious, recombinant parvoviral capsid particles, or β-antigen-blocking portions thereof, for the manufacture of drugs for inhibiting hematopoietic stem cells

Publications (1)

Publication Number	Publication Date
PL348640A1 true PL348640A1 (en)	2002-06-03

Family

ID=20413393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99348640A PL348640A1 (en)	1998-11-24	1999-11-23	Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Country Status (14)

Country	Link
EP (1)	EP1131085A2 (en)
JP (1)	JP2003516927A (en)
KR (1)	KR20010080518A (en)
CN (1)	CN1328469A (en)
AU (1)	AU2566600A (en)
CA (1)	CA2352043A1 (en)
CZ (1)	CZ20011369A3 (en)
HU (1)	HUP0104298A2 (en)
IS (1)	IS5931A (en)
MX (1)	MXPA01004949A (en)
NO (1)	NO20012534L (en)
PL (1)	PL348640A1 (en)
SE (1)	SE520177C2 (en)
WO (1)	WO2000030668A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE345352T1 (en)	2001-07-10	2006-12-15	Deutsches Krebsforsch	COMPOSITION OF A PARVOVIRUS VP1 PROTEIN VARIANT AND AN ARVOVIRUS NS1 PROTEIN FOR INDUCING CYTOLYSIS
ES2344739T3 (en) *	2004-09-24	2010-09-06	Intercell Ag	VP1 MODIFIED CAPSIDIAL PROTEIN OF PARVOVIRUS B19.
CN101475942B (en) *	2008-11-28	2012-05-23	中国人民解放军第四军医大学	B19 virus VP1 unique region gene
WO2012159006A2 (en) *	2011-05-18	2012-11-22	University Of Florida Research Foundation, Inc.	Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2755817B2 (en) *	1988-11-14	1998-05-25	アメリカ合衆国	Parvovirus capsid
NL8902301A (en) *	1989-09-14	1991-04-02	Rijksuniversiteit	HUMAN PARVOVIRUS B19 PROTEINS, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC ASSAYS AND VACCINES.

1998
- 1998-11-24 SE SE9804022A patent/SE520177C2/en not_active IP Right Cessation
1999
- 1999-11-23 KR KR1020017006374A patent/KR20010080518A/en not_active Application Discontinuation
- 1999-11-23 WO PCT/IB1999/002112 patent/WO2000030668A2/en not_active Application Discontinuation
- 1999-11-23 JP JP2000583551A patent/JP2003516927A/en active Pending
- 1999-11-23 AU AU25666/00A patent/AU2566600A/en not_active Abandoned
- 1999-11-23 EP EP99968407A patent/EP1131085A2/en not_active Withdrawn
- 1999-11-23 MX MXPA01004949A patent/MXPA01004949A/en unknown
- 1999-11-23 CZ CZ20011369A patent/CZ20011369A3/en unknown
- 1999-11-23 PL PL99348640A patent/PL348640A1/en unknown
- 1999-11-23 CN CN99813653A patent/CN1328469A/en active Pending
- 1999-11-23 CA CA002352043A patent/CA2352043A1/en not_active Abandoned
- 1999-11-23 HU HU0104298A patent/HUP0104298A2/en unknown
2001
- 2001-05-02 IS IS5931A patent/IS5931A/en unknown
- 2001-05-23 NO NO20012534A patent/NO20012534L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2000030668A9 (en)	2001-04-05
SE9804022L (en)	2000-05-25
MXPA01004949A (en)	2003-03-10
CN1328469A (en)	2001-12-26
CA2352043A1 (en)	2000-06-02
AU2566600A (en)	2000-06-13
EP1131085A2 (en)	2001-09-12
NO20012534D0 (en)	2001-05-23
WO2000030668A2 (en)	2000-06-02
KR20010080518A (en)	2001-08-22
WO2000030668A8 (en)	2000-09-14
SE9804022D0 (en)	1998-11-24
CZ20011369A3 (en)	2001-10-17
SE520177C2 (en)	2003-06-03
NO20012534L (en)	2001-06-29
WO2000030668A3 (en)	2000-11-09
JP2003516927A (en)	2003-05-20
HUP0104298A2 (en)	2002-03-28
IS5931A (en)	2001-05-02

Similar Documents

Publication	Publication Date	Title
SG55368A1 (en)	1998-12-21	Abrasive composition and use of the same
GB9815271D0 (en)	1998-09-09	Particles and devices comprising particles
HUP0001020A3 (en)	2001-10-29	Stanol composition and the use thereof
HUP0201887A2 (en)	2002-09-28	Conditioned cell culture medium compositions and methods of use
IL139786A0 (en)	2002-02-10	Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
PL335424A1 (en)	2000-04-25	Heterocyclic compounds and their application in inhibiting beta-amyloid peptide secretion
IL138502A0 (en)	2001-10-31	Cell differentiation/ proliferation and maintenaince factor and uses thereof
GB9813271D0 (en)	1998-08-19	Composition and use
HK1020259A1 (en)	2000-04-07	Composition for use in the treatment and prevention of hyperuricemia.
HUP0000595A2 (en)	2000-07-28	Mixture of alkoxylates with an antifoaming disinfectant effect and the use thereof in cleaning materials
GB2327669B (en)	2001-08-15	Coated aggregate particles for use in construction and methods of making same
HU9900840D0 (en)	1999-05-28	Mixtures of pastes based on cellulose and the use thereof in coatings
EP0980202A4 (en)	2001-03-14	Methods for viral inactivation and compositions for use in same
EP0947581A4 (en)	2004-07-28	Culture medium and use of the same
PL348640A1 (en)	2002-06-03	Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
GB9421704D0 (en)	1994-12-14	Absorbent materials and uses thereof
HUP0104723A3 (en)	2004-10-28	New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9815270D0 (en)	1998-09-09	Particles and devices comprising particles
AU4706199A (en)	2000-01-10	Compositions and methods for inducing apoptosis in e6-expressing cells
IL132312A0 (en)	2001-03-19	Use of leptin in inhibition of endothelial cell proliferation
HUP0104954A3 (en)	2004-07-28	Prv-1 gene and the use thereof
ZA981322B (en)	1998-09-07	Pyridazin-3-one derivatives and their use
AU3340399A (en)	1999-10-25	Use of urocortin and like polypeptides in therapy
EP0974648A4 (en)	2002-11-20	Novel cell line and screening method with the use of the same
GB9724752D0 (en)	1998-01-21	Improvements in the holding and control of hedgecutters